Clinical trial · Observational
Natural History Study of Patients With Chronic Myelogenous Leukemia
Chronic Myeloid Leukemia (CML) Cohort
NCT00429910CI-TRIAL-00025324completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Gathering information about patients with chronic myelogenous leukemia may help doctors learn more about the disease and find better methods of treatment and on-going care. PURPOSE: This natural history study is collecting health information and disease-related information over time from patients with newly diagnosed chronic myelogenous leukemia.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (5)
- measure
- Impact of current procedures for diagnosis, management, and follow-up on disease status
- timeFrame
- 5 years
- measure
- Natural history of patients with chronic myelogenous leukemia who achieve response to imatinib mesylate
- timeFrame
- 5 years
- measure
- Health perceptions, symptoms, insurance issues, and work issues
- timeFrame
- 5 years
- measure
- Affect of medication compliance and planned dose reduction on imatinib mesylate effectiveness
- timeFrame
- 5 years
- measure
- Molecular and biologic factors associated with disease progression and good and poor response to imatinib mesylate
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 120 Years
Show eligibility criteria text
Age 18 years and over Diagnosis within one year of enrollment
References
Publications (0)
Data not yet available
No reference posted for this study.